Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewTocriscreen FDA-Approved Drugs Library is a library of 190 compounds equivalent to the pharmacologically active components of drug formulations approved by the FDA. Compounds supplied pre-dissolved in DMSO (100 μL, 10 mM solution). Contains compounds covering a diverse range of pharmaceutical targets and therapeutic areas e.g. immunology, oncology. Includes both established therapeutics, e.g. tamoxifen (Cat. No. 0999) and paclitaxel (Cat. No. 1097), as well as more recently approved drugs such as darunavir (Cat. No. 6710) and sorafenib (Cat. No. 6814). Ideal for in vitro and in vivo drug repurposing/repositioning studies.
This library replaces the Tocriscreen Library of FDA-Approved Compounds (Cat. No. 5932).
All Tocris products are for biomedical research use only. They are not intended for human or veterinary use.
The Tocriscreen FDA-approved Drugs Library contains bioactive compounds covering a diverse range of therapeutic classifications, derived using the WHO Anatomical Therapeutic Chemical Classification System code (ATC code).
To request a list of the compounds available in the Tocriscreen FDA-Approved Drugs Library please click the request tile below. Compound lists can be provided in Excel or SD format.
Request compound list for Tocriscreen FDA-Approved Drugs Library
Storage | Store at -20°C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Li et al (2015) Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 17 195 PMID: 26253201
Edwards et al (2014) The University of New Mexico Center for Molecular Discovery. Comb.Chem.High Throughput Screen. 17 256 PMID: 24409953
If you know of a relevant reference for Tocriscreen FDA-Approved Drugs Library, please let us know.
Keywords: Tocriscreen FDA-Approved Drugs Library, Tocriscreen FDA-Approved Drugs Library supplier, biologically, active, pre-dissolved, DMSO, 10mM, solutions, Tocriscreen, Compound, Collections, Screening, Library, Libraries, HTS, HCS, high, throughput, content, FDA-approved, drug, library, repurposing, target, validation, repositioning, 7200, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Tocriscreen FDA-Approved Drugs Library include:
Shin et al (2018) Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro. Viruses 10 E283 PMID: 29795047
Edmister et al (2022) Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles. Sci.Rep. 12 6120 PMID: 35449173
Chaffey et al (2024) Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages. Eur.J.Pharmacol. 969 176437 PMID: 38417608
Gore et al (2023) Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae. Sci.Rep. 13 3174 PMID: 36823315
Kim et al (2023) Nebivolol sensitizes BT-474 breast cancer cells to FGFR inhibitors. Anticancer Res. 43 1973 PMID: 37097659
Gull et al (2023) Screening of chemical libraries using xenopus embryos and tadpoles for phenotypic drug discovery. Cold Spring Harb.Protoc. PMID: 36180216
Mehyar et al (2020) Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase. SAR QSAR Environ Res 6 1 PMID: 33401979
Do you know of a great paper that uses Tocriscreen FDA-Approved Drugs Library from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Tocriscreen FDA-Approved Drugs Library and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image